Is Tela Bio Inc (TELA) overvalued? · rev $38.4M
Tela Bio Inc (TELA) is a medical devices company listed on NASDAQ.
This page asks whether Tela Bio Inc (TELA) looks expensive on cached numbers — not a short thesis.
Latest reported TELA revenue for 2026-06-30 was $38.4M. Net income was -$23.5M. TELA currently screens at market cap $38.5M.
TELA currently screens at market cap $38.5M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TELA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TELA stock page for the full model, not this heading.
Not investment advice.